Company profile ZVRA

Zevra Therapeutics Inc
kempharm is a biopharmaceutical company focused on the discovery and development of new chemical entities (nces) to treat serious medical conditions through its proprietary and broadly applicable ligand activated therapy (lat) approach. the company utilizes its lat technology to generate improved prodrug versions of fda approved drugs in the high needs areas of pain, adhd and o...ther cns diseases. Show More
Quarter analysis & expected interestLast update: February 09 2024 08:06:46.

After 39 days of this quarter the interest is at 22.0. Based on that we can calculate that during remaining 52 days it will total up to 51.0.
zevra therapeutics expected interest is significantly lower compared to previous quarter (-76.2%) and same quarter last year (-51.0%).

YearQ1Q2Q3Q4
201955
20
-63.6% QoQ
0
-100.0% QoQ
114
inf% QoQ
2020 29
-47.3% YoY -74.6% QoQ
108
440.0% YoY 272.4% QoQ
101
inf% YoY -6.5% QoQ
47
-58.8% YoY -53.5% QoQ
2021 113
289.7% YoY 140.4% QoQ
198
83.3% YoY 75.2% QoQ
107
5.9% YoY -46.0% QoQ
98
108.5% YoY -8.4% QoQ
2022 191
69.0% YoY 94.9% QoQ
146
-26.3% YoY -23.6% QoQ
197
84.1% YoY 34.9% QoQ
193
96.9% YoY -2.0% QoQ
2023 104
-45.5% YoY -46.1% QoQ
275
88.4% YoY 164.4% QoQ
221
12.2% YoY -19.6% QoQ
214
10.9% YoY -3.2% QoQ
2024 22
-78.8% YoY -89.7% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and zevra therapeutics search interestLast update: February 09 2024 08:06:44.
Correlation coefficient between keyword and revenue is 0.76
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 08:06:47.

The average 5 years interest of zevra therapeutics was 9.78 per week.
The last year interest of zevra therapeutics compared to the last 5 years has changed by 59.51%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 329.75%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 08:06:55.

After 39 days of this quarter the interest is at 65.0. Based on that we can calculate that during remaining 52 days it will total up to 152.0.
zevra therapeutics stock expected interest is significantly higher compared to previous quarter (+744.4%) and same quarter last year (+inf%).

YearQ1Q2Q3Q4
201951
46
-9.8% QoQ
85
84.8% QoQ
97
14.1% QoQ
2020 28
-45.1% YoY -71.1% QoQ
60
30.4% YoY 114.3% QoQ
30
-64.7% YoY -50.0% QoQ
151
55.7% YoY 403.3% QoQ
2021 89
217.9% YoY -41.1% QoQ
122
103.3% YoY 37.1% QoQ
0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
2022 159
78.7% YoY inf% QoQ
17
-86.1% YoY -89.3% QoQ
42
inf% YoY 147.1% QoQ
0
inf% YoY -100.0% QoQ
2023 0
-100.0% YoY -100.0% QoQ
97
470.6% YoY inf% QoQ
77
83.3% YoY -20.6% QoQ
18
inf% YoY -76.6% QoQ
2024 65
inf% YoY 261.1% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and zevra therapeutics stock search interestLast update: February 09 2024 08:06:55.
Correlation coefficient between keyword and revenue is 0.92
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 08:06:57.

The average 5 years interest of zevra therapeutics stock was 4.73 per week.
The last year interest of zevra therapeutics stock compared to the last 5 years has changed by 4.44%.
This is something to be checked.
The last year interest is comparable to 5 years ago. It has changed only by -8.01%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for zevra therapeutics news to provide analysis

Correlation between past revenue and zevra therapeutics news search interest

There is not enough data for zevra therapeutics news to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for zevra therapeutics news to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for zevra therapeutics clinical trials to provide analysis

Correlation between past revenue and zevra therapeutics clinical trials search interest

There is not enough data for zevra therapeutics clinical trials to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for zevra therapeutics clinical trials to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for zevra therapeutics products to provide analysis

Correlation between past revenue and zevra therapeutics products search interest

There is not enough data for zevra therapeutics products to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for zevra therapeutics products to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for zevra therapeutics pipeline to provide analysis

Correlation between past revenue and zevra therapeutics pipeline search interest

There is not enough data for zevra therapeutics pipeline to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for zevra therapeutics pipeline to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for zevra therapeutics investors to provide analysis

Correlation between past revenue and zevra therapeutics investors search interest

There is not enough data for zevra therapeutics investors to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for zevra therapeutics investors to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for zevra therapeutics contact to provide analysis

Correlation between past revenue and zevra therapeutics contact search interest

There is not enough data for zevra therapeutics contact to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for zevra therapeutics contact to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for zevra therapeutics headquarters to provide analysis

Correlation between past revenue and zevra therapeutics headquarters search interest

There is not enough data for zevra therapeutics headquarters to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for zevra therapeutics headquarters to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for zevra therapeutics website to provide analysis

Correlation between past revenue and zevra therapeutics website search interest

There is not enough data for zevra therapeutics website to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for zevra therapeutics website to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for ZVRA
Earnings date: 2024-03-05 After close
Company name: Zevra Therapeutics Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-12T11:30:00Z

GlobeNewswire
Zevra Therapeutics to Present at the H.C. Wainwright BioConnect Investor Conference

2026-05-08T13:29:27Z

Analyst Upgrades
Guggenheim Maintains Buy on Zevra Therapeutics, Raises Price Target to $25

2026-05-06T20:05:00Z

GlobeNewswire
Zevra Reports First Quarter 2026 Financial Results and Corporate Update

2026-04-22T11:30:00Z

GlobeNewswire
Zevra Therapeutics Announces Details for Q1 2026 Financial Results Call

2026-03-16T11:37:30Z

Analyst Upgrades
This Cohu Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

2026-03-16T11:30:00Z

GlobeNewswire
Zevra Therapeutics Sells SDX Portfolio to Commave Therapeutics for $50 Million

2026-03-16T10:45:39Z

Analyst Upgrades
BTIG Initiates Coverage On Zevra Therapeutics with Buy Rating, Announces Price Target of $23

2026-03-10T12:30:00Z

BusinessWire
GeneDx to Launch Genetic Testing Program with Zevra Therapeutics to Support Patients with Suspected Niemann-Pick Disease Type C

2026-03-09T20:05:00Z

GlobeNewswire
Zevra Reports Fourth Quarter and Full Year 2025 Financial Results

2026-03-05T12:30:00Z

GlobeNewswire
Zevra Therapeutics Appoints Justin Renz as Chief Financial Officer

2026-03-02T12:30:00Z

GlobeNewswire
Zevra Therapeutics Announces Details for Q4 and Full Year 2025 Financial Results Call

2026-02-25T12:30:00Z

GlobeNewswire
Zevra Therapeutics to Present at the Citizens Life Sciences Conference

2026-02-24T20:42:26Z

GlobeNewswire
Transpire Bio Strengthens its Leadership Team with Appointment of LaDuane Clifton as Chief Financial Officer

2026-02-04T12:30:00Z

GlobeNewswire
Zevra Therapeutics Presents Positive New Real-World Data on MIPLYFFA® in Patients with Neimann-Pick Disease Type C (NPC) at the 22nd Annual WORLDSymposium™

2026-02-02T12:30:00Z

GlobeNewswire
Zevra Therapeutics to Ring Nasdaq Stock Market Opening Bell on Monday, February 9, 2026